Literature DB >> 411741

Adjuvant activities of chemically modified water-soluble substances from Mycobacterium tuberculosis.

D Migliore-Samour, F Floc'h, R Maral, G H Werner, P Jollès.   

Abstract

Water-soluble peptidoglycan fragments extracted from the cells of two strains of Mycobacterium tuberculosis var. hominis were chemically conjugated with lauric or with palmitic acid. The coupling reaction was confirmed by physicochemical procedures. The native and the fatty acid-conjugated substances were studied for their adjuvant activity in the induction of delayed type hypersensitivity (DTH) reactions in guinea-pigs and on the production of circulating antibodies in the rabbit. Palmitic acid conjugation of one of the substances increased its adjuvanticity on DTH in the presence of mineral oil; lauric or palmitic acid conjugation rendered the substances adjuvant-active on DTH in the absence of mineral oil. Lauric acid, but not palmitic acid conjugation conferred on both substances an adjuvant activity on antibody production in the absence of mineral oil. Furthermore, lauric acid conjugation of one of the substances led to the appearance of an in vitro mitogen-like activity for murine spleen lymphocytes. In conclusion, fatty acid conjugation exerted a significant modifying effect on the immuno-potentiating activities of these peptidoglycan fragments, and such a chemical procedure may lead to the development of substances exerting a full adjuvant activity without the need of injecting them in an oily vehicle.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 411741      PMCID: PMC1445381     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  [The lipids of the Brevannes human strain of Mycobacterium tuberculosis].

Authors:  A AEBI; J ASSELINEAU; E LEDERER
Journal:  Bull Soc Chim Biol (Paris)       Date:  1953

2.  Adjuvant and immunostimulating activities of water-soluble substances extracted from Mycobacterium tuberculosis (var. hominis).

Authors:  G H Werner; R Maral; F Floch; D Migliore-Samour; P Jollès
Journal:  Biomedicine       Date:  1975-09

3.  Water-soluble and lipid-free fraction from BCG with adjuvant and antitumour activity.

Authors:  I J Hiu
Journal:  Nat New Biol       Date:  1972-08-23

4.  Isolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis.

Authors:  A Adam; R Ciorbaru; J F Petit; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

5.  Delayed hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine. In vivo and in vitro study.

Authors:  C Nauciel; M Raynaud
Journal:  Eur J Immunol       Date:  1971-08       Impact factor: 5.532

6.  Hydrosoluble adjuvant-active mycobacterial fractions of low molecular weight.

Authors:  D Migliore-Samour; P Jollès
Journal:  FEBS Lett       Date:  1973-09-15       Impact factor: 4.124

7.  Hydrosoluble immunopotentiating substances extraced from Corynebacterium parvum.

Authors:  D Migliore-Samour; M Korontzis; P Jollès
Journal:  Immunol Commun       Date:  1974

8.  Adjuvant activity in delayed hypersensitivity of the peptidic part of bacterial peptidoglycans.

Authors:  J Fleck; M Mock; F Tytgat; C Nauciel; R Minck
Journal:  Nature       Date:  1974-08-09       Impact factor: 49.962

9.  Separation of dansyl-amino acids by polyamide layer chromatography.

Authors:  K R Woods; K T Wang
Journal:  Biochim Biophys Acta       Date:  1967-02-21

10.  STUDIES ON ARTIFICIAL ANTIGENS. II. THE ANTIGENICITY IN GUINEA PIGS OF ARSANILIC ACID CONJUGATES OF COPOLYMERS OF D- OR L-ALPHA-AMINO ACIDS.

Authors:  B BENACERRAF; A OJEDA; P H MAURER
Journal:  J Exp Med       Date:  1963-12-01       Impact factor: 14.307

View more
  1 in total

1.  The effect of bacterial peptidoglycans on the immune response of hamsters to influenza virus vaccines.

Authors:  C R Crawford; R Jennings; N Bradford; C W Potter
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.